Quality investors are looking for the best of the best. Companies which are growing steadily and consistently, but are also in excellent financial condition. We will have a look here to see if NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) is suited for quality investing. Investors should of course do their own research, but we spotted NEUROCRINE BIOSCIENCES INC showing up in our Caviar Cruise quality screen, so it may be worth spending some more time on it.
What matters for quality investors.
Over the past 5 years, NEUROCRINE BIOSCIENCES INC has experienced impressive revenue growth, with 33.13% increase. This demonstrates the company's ability to effectively expand its top line and suggests a positive outlook for future revenue generation.
With a robust ROIC excluding cash and goodwill at 38.85%, NEUROCRINE BIOSCIENCES INC showcases its effective allocation of capital and operational excellence. This metric signifies the company's ability to generate attractive returns and supports its long-term financial performance.
With a favorable Debt/Free Cash Flow Ratio of 0.47, NEUROCRINE BIOSCIENCES INC showcases its sound financial discipline and cash flow management. This ratio indicates the company's ability to service its debt obligations while maintaining sufficient free cash flow for future investments or operational needs.
With a robust Profit Quality (5-year) ratio of 208.0%, NEUROCRINE BIOSCIENCES INC highlights its ability to consistently generate high-quality profits. This metric reflects the company's effective management and operational excellence in delivering reliable earnings over the long term.
NEUROCRINE BIOSCIENCES INC has demonstrated consistent growth in EBIT over the past 5 years, with a strong 60.65%. This signifies the company's ability to generate sustainable earnings and reflects its positive financial trajectory.
NEUROCRINE BIOSCIENCES INC demonstrates a remarkable trend where its EBIT 5-year growth exceeds its Revenue 5-year growth. This indicates the company's ability to enhance its profitability through improved cost control and operational efficiency.
A complete fundamental analysis of NASDAQ:NBIX
ChartMill employs a sophisticated system to assign a Fundamental Rating to every stock in its analysis. This rating, which ranges from 0 to 10, is determined by carefully assessing multiple fundamental indicators and properties.
Overall NBIX gets a fundamental rating of 8 out of 10. We evaluated NBIX against 598 industry peers in the Biotechnology industry. NBIX has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. NBIX is growing strongly while it also seems undervalued. This is an interesting combination With these ratings, NBIX could be worth investigating further for value and growth and quality investing!.
Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.